| | | 58935 | | 28.10.2008 | | Future Health Pharma GmbH | | | | | | | 27.10.2023 | | | | | | 02.07.20. | | 08.11.2023 | | 02.07.20. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Rasilez HCT 150mg/12.5mg | Filmtabletten | Filmtabletten (Aliskirenum 150 mg, Hydrochlorothiazid 12.5 mg) | C09XA52 | PI | | 02 | Rasilez HCT 150mg/25mg | Filmtabletten | Filmtabletten (Aliskirenum 150 mg, Hydrochlorothiazid 25 mg) | C09XA52 | PI | | 03 | Rasilez HCT 300mg/12.5mg | Filmtabletten | Filmtabletten (Aliskirenum 300 mg, Hydrochlorothiazid 12.5 mg) | C09XA52 | PI | | 04 | Rasilez HCT 300mg/25mg | Filmtabletten | Filmtabletten (Aliskirenum 300 mg, Hydrochlorothiazid 25 mg) | C09XA52 | PI |
|
|
